CUV 0.85% $15.37 clinuvel pharmaceuticals limited

news, mentions ept , page-4

  1. 1,363 Posts.
    ........theory...... Having thought a little about the position MBP finds itself in EPT are looking extremely good.

    MBP have a similar market potential to EPT, but their market cap is almost 5 x that of EPT. Both are about to enter Phase III trials and trying to hook up a JV partner to fund it ($20-30 Mil).

    So a JV parner with MBP might end up with 4% of the company compared to a JV partner with EPT ending up with 15%.

    EPT are clearly in a strong position to entice a partner. Perhaps this is why Millen has been selling? In doing so he sends a bad message to the market , but at the same time keeps the s.p down so as the leverage for JV partner is maintained.

    That's my theory anyway, what do you think?


    cheers, stainless
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.37
Change
0.130(0.85%)
Mkt cap ! $770.0M
Open High Low Value Volume
$15.36 $15.54 $15.18 $1.274M 82.63K

Buyers (Bids)

No. Vol. Price($)
1 237 $15.31
 

Sellers (Offers)

Price($) Vol. No.
$15.50 282 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.